Sign In
Buy TECH
$56.26
+0.650 (+1.17%)
At Close: Jun 23, 2026
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
10:20am, Tuesday, 24'th May 2022 Zacks Investment Research
Smart Beta ETF report for PBE
Bio-Techne Corporation (TECH) CEO Chuck Kummeth on Q3 2022 Results - Earnings Call Transcript
12:18pm, Wednesday, 04'th May 2022
Bio-Techne Corporation (NASDAQ:TECH ) Q3 2022 Earnings Conference Call May 4, 2022 9:00 AM ET Company Participants David Clair - Senior Director, IR and Corporate Development Chuck Kummeth - CEO Jim H
Techne (TECH) Beats Q3 Earnings and Revenue Estimates
11:55am, Wednesday, 04'th May 2022 Zacks Investment Research
Techne (TECH) delivered earnings and revenue surprises of 7% and 2.47%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Techne (TECH) Beats Q3 Earnings and Revenue Estimates
09:02am, Wednesday, 04'th May 2022
Techne (TECH) delivered earnings and revenue surprises of 7% and 2.47%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
HZNP or TECH: Which Is the Better Value Stock Right Now?
03:40pm, Tuesday, 03'rd May 2022 Zacks Investment Research
HZNP vs. TECH: Which Stock Is the Better Value Option?
HZNP or TECH: Which Is the Better Value Stock Right Now?
12:48pm, Tuesday, 03'rd May 2022
HZNP vs. TECH: Which Stock Is the Better Value Option?
Should Vanguard SmallCap Growth ETF (VBK) Be on Your Investing Radar?
10:20am, Monday, 02'nd May 2022 Zacks Investment Research
Style Box ETF report for VBK
BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
07:00am, Monday, 02'nd May 2022
MINNEAPOLIS , May 2, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the BofA Securities 2022 Hea
Gilead Sciences (GILD) Beats Q1 Earnings and Revenue Estimates
09:25pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Gilead (GILD) delivered earnings and revenue surprises of 19.77% and 6.46%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022
02:07pm, Monday, 25'th Apr 2022 Benzinga
Upgrades
RBC Capital upgraded the previous rating for United States Steel Corp (NYSE:X) from Sector Perform to Outperform. United States Steel earned $3.64 in the fourth quarter, compared to $0.27 in
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?
10:20am, Tuesday, 19'th Apr 2022 Zacks Investment Research
Sector ETF report for PBE
This 10.3% Dividend, At A 13.3% Discount, Is Perfect For A Fed-Driven Market
09:09am, Thursday, 07'th Apr 2022 Investing.com
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
10:20am, Monday, 21'st Mar 2022 Zacks Investment Research
Smart Beta ETF report for PBE
Investors have been scared out of this group of stocks, says fund manager, who offers five ideas for the rebound to come.
02:41pm, Wednesday, 16'th Mar 2022 MarketWatch
Risk-averse investors have been shunning small-cap stocks, but look for the clouds to clear soon over this asset class, says a fund manager at Artemis.
